The physiological and molecular regulation of lipoprotein assembly and secretion

被引:91
作者
Blasiole, Daniel A.
Davis, Roger A.
Attie, Alan D.
机构
[1] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
[2] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA
关键词
D O I
10.1039/b700706j
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Triglycerides are insoluble in water and yet are transported at milligram per millilitre concentrations in the bloodstream. This is made possible by the ability of the liver and intestine to assemble lipid - protein emulsions (i.e. lipoproteins), which transport hydrophobic molecules. The assembly of triglyceride-rich lipoproteins requires the coordination of protein and lipid synthesis, which occurs on the cytoplasmic surface of the endoplasmic reticulum ( ER), and their concerted assembly and translocation into the luminal ER secretory pathway as nascent lipoprotein particles. The availability of lipid substrate for triglyceride production and the machinery for lipoprotein assembly are highly sensitive to nutritional, hormonal, and genetic modulation. Disorders in lipid metabolism or an imbalance between lipogenesis and lipoprotein assembly can lead to hyperlipidemia and/or hepatic steatosis. We selectively review recently-identified machinery, such as transcription factors and nuclear hormone receptors, which provide new clues to the regulation of lipoprotein secretion.
引用
收藏
页码:608 / 619
页数:12
相关论文
共 177 条
[1]   Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes [J].
Allister, EM ;
Borradaile, NM ;
Edwards, JY ;
Huff, MW .
DIABETES, 2005, 54 (06) :1676-1683
[2]   Activation of peroxisome proliferator-activated receptor α increases the expression and activity of microsomal triglyceride transfer protein in the liver [J].
Améen, C ;
Edvardsson, U ;
Ljungberg, A ;
Asp, L ;
Åkerblad, P ;
Tuneld, A ;
Olofsson, SO ;
Lindén, D ;
Oscarsson, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (02) :1224-1229
[3]   Molecular mechanisms of apolipoprotein B mRNA editing [J].
Anant, S ;
Davidson, NO .
CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (02) :159-165
[4]  
ANGELIN B, 1978, J LIPID RES, V19, P1017
[5]   Insulin regulates hepatic apolipoprotein B production independent of the mass or activity of Akt1/PKBα [J].
Au, CS ;
Wagner, A ;
Chong, T ;
Qiu, W ;
Sparks, JD ;
Adeli, K .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (02) :228-235
[6]   Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells -: Roles of MAPKerk and MAPKp38 [J].
Au, WS ;
Kung, HF ;
Lin, MC .
DIABETES, 2003, 52 (05) :1073-1080
[7]   Decreased secretion of ApoB follows inhibition of ApoB-MTP binding by a novel antagonist [J].
Bakillah, A ;
Nayak, N ;
Saxena, U ;
Medford, RM ;
Hussain, MM .
BIOCHEMISTRY, 2000, 39 (16) :4892-4899
[8]   Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states [J].
Barrows, BR ;
Parks, EJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (04) :1446-1452
[9]   Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice [J].
Bartels, ED ;
Lauritsen, M ;
Nielsen, LB .
DIABETES, 2002, 51 (04) :1233-1239
[10]   EFFECTS OF INTERRUPTION OF THE ENTEROHEPATIC CIRCULATION OF BILE-ACIDS ON THE TRANSPORT OF VERY LOW-DENSITY LIPOPROTEIN TRIGLYCERIDES [J].
BEIL, U ;
CROUSE, JR ;
EINARSSON, K ;
GRUNDY, SM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1982, 31 (05) :438-444